138 related articles for article (PubMed ID: 38184096)
1. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Overbeek KA; Poulsen JL; Lanzillotta M; Vinge-Holmquist O; Macinga P; Demirci AF; Sindhunata DP; Backhus J; Algül H; Buijs J; Levy P; Kiriukova M; Goni E; Hollenbach M; Miksch RC; Kunovsky L; Vujasinovic M; Nikolic S; Dickerson L; Hirth M; Neurath MF; Zumblick M; Vila J; Jalal M; Beyer G; Frost F; Carrara S; Kala Z; Jabandziev P; Sisman G; Akyuz F; Capurso G; Falconi M; Arlt A; Vleggaar FP; Barresi L; Greenhalf B; Czakó L; Hegyi P; Hopper A; Nayar MK; Gress TM; Vitali F; Schneider A; Halloran CM; Trna J; Okhlobystin AV; Dagna L; Cahen DL; Bordin D; Rebours V; Mayerle J; Kahraman A; Rasch S; Culver E; Kleger A; Martínez-Moneo E; Røkke O; Hucl T; Olesen SS; Bruno MJ; Della-Torre E; Beuers U; Löhr JM; Rosendahl J;
Clin Gastroenterol Hepatol; 2024 May; 22(5):994-1004.e10. PubMed ID: 38184096
[TBL] [Abstract][Full Text] [Related]
2. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.
Matsubayashi H; Ishiwatari H; Imai K; Kishida Y; Ito S; Hotta K; Yabuuchi Y; Yoshida M; Kakushima N; Takizawa K; Kawata N; Ono H
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905944
[TBL] [Abstract][Full Text] [Related]
3. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune pancreatitis not otherwise specified (NOS): Clinical features and outcomes of the forgotten type.
de Pretis N; Vieceli F; Brandolese A; Brozzi L; Amodio A; Frulloni L
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):576-579. PubMed ID: 31248720
[TBL] [Abstract][Full Text] [Related]
5. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Pancreatitis: From Pathogenesis to Treatment.
Nista EC; De Lucia SS; Manilla V; Schepis T; Pellegrino A; Ojetti V; Pignataro G; Zileri Dal Verme L; Franceschi F; Gasbarrini A; Candelli M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293522
[TBL] [Abstract][Full Text] [Related]
7. Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency.
Barresi L; Tacelli M; Crinò SF; Attili F; Petrone MC; De Nucci G; Carrara S; Manfredi G; Capurso G; De Angelis CG; Crocellà L; Fantin A; Dore MF; Garribba AT; Tarantino I; De Pretis N; Pagliari D; Rossi G; Manes G; Preatoni P; Barbuscio I; Tuzzolino F; Traina M; Frulloni L; Costamagna G; Arcidiacono PG; Buscarini E; Pezzilli R;
United European Gastroenterol J; 2020 Jul; 8(6):705-715. PubMed ID: 32397913
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population.
Liu B; Li J; Yan LN; Sun HR; Liu T; Zhang ZX
World J Gastroenterol; 2013 Jan; 19(4):569-74. PubMed ID: 23382638
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.
Hart PA; Kamisawa T; Brugge WR; Chung JB; Culver EL; Czakó L; Frulloni L; Go VL; Gress TM; Kim MH; Kawa S; Lee KT; Lerch MM; Liao WC; Löhr M; Okazaki K; Ryu JK; Schleinitz N; Shimizu K; Shimosegawa T; Soetikno R; Webster G; Yadav D; Zen Y; Chari ST
Gut; 2013 Dec; 62(12):1771-6. PubMed ID: 23232048
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune pancreatitis: Cornerstones and future perspectives.
Gallo C; Dispinzieri G; Zucchini N; Invernizzi P; Massironi S
World J Gastroenterol; 2024 Feb; 30(8):817-832. PubMed ID: 38516247
[TBL] [Abstract][Full Text] [Related]
11. Impact of sclerosing dacryoadenitis/sialadenitis on relapse during steroid therapy in patients with type 1 autoimmune pancreatitis.
Ishii Y; Serikawa M; Sasaki T; Fujimoto Y; Yamaguchi A; Ogawa T; Noma B; Okazaki A; Yukutake M; Ishigaki T; Chayama K
Scand J Gastroenterol; 2019 Feb; 54(2):259-264. PubMed ID: 30915865
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge.
Xiang P; Zhang X; Wang C; Lang Y; Xu L; Huang L; Shen J; Feng ST
BMC Cancer; 2019 Aug; 19(1):814. PubMed ID: 31419961
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.
Minaga K; Watanabe T; Hara A; Kamata K; Omoto S; Nakai A; Otsuka Y; Sekai I; Yoshikawa T; Yamao K; Takenaka M; Chiba Y; Kudo M
Sci Rep; 2020 Sep; 10(1):14879. PubMed ID: 32938972
[TBL] [Abstract][Full Text] [Related]
14. Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune Pancreatitis.
Fukiage A; Fujino H; Miki D; Ishii Y; Serikawa M; Tsuge M; Imamura M; Aikata H; Hayes CN; Chayama K
Dig Dis Sci; 2021 Apr; 66(4):1268-1275. PubMed ID: 32436125
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.
Kubota K; Kamisawa T; Hirano K; Hirooka Y; Uchida K; Ikeura T; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Okazaki K; Kawa S; Shimosegawa T; Takeyama Y; Chiba T
J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):223-230. PubMed ID: 29430861
[TBL] [Abstract][Full Text] [Related]
16. Surgery in Autoimmune Pancreatitis.
Nikolic S; Ghorbani P; Pozzi Mucelli R; Ghazi S; Baldaque-Silva F; Del Chiaro M; Sparrelid E; Verbeke CS; Löhr JM; Vujasinovic M
Dig Surg; 2022; 39(1):32-41. PubMed ID: 34915509
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis.
Tacelli M; Celsa C; Magro B; Barresi L; Guastella S; Capurso G; Frulloni L; Cabibbo G; Cammà C
Clin Gastroenterol Hepatol; 2019 May; 17(6):1061-1072.e8. PubMed ID: 30312787
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
[TBL] [Abstract][Full Text] [Related]
19. Steroid treatment response combined with serological mark in differentiating type-1 autoimmune pancreatitis from pancreatic cancer.
Liu B; Tang N; Yao Y; Li H; Xu L; Zhou B; Liu B
Medicine (Baltimore); 2022 Nov; 101(45):e31660. PubMed ID: 36397434
[TBL] [Abstract][Full Text] [Related]
20. Republished: recent advances in autoimmune pancreatitis: type 1 and type 2.
Kamisawa T; Chari ST; Lerch MM; Kim MH; Gress TM; Shimosegawa T
Postgrad Med J; 2014 Jan; 90(1059):18-25. PubMed ID: 24336310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
